Intracellular delivery by membrane disruption: mechanisms, strategies, and concepts

MP Stewart, R Langer, KF Jensen - Chemical reviews, 2018 - ACS Publications
Intracellular delivery is a key step in biological research and has enabled decades of
biomedical discoveries. It is also becoming increasingly important in industrial and medical …

Induced pluripotency: history, mechanisms, and applications

M Stadtfeld, K Hochedlinger - Genes & development, 2010 - genesdev.cshlp.org
The generation of induced pluripotent stem cells (iPSCs) from somatic cells demonstrated
that adult mammalian cells can be reprogrammed to a pluripotent state by the enforced …

Organ engineering based on decellularized matrix scaffolds

JJ Song, HC Ott - Trends in molecular medicine, 2011 - cell.com
End-organ failure is one of the major healthcare challenges in the Western world. Yet, donor
organ shortage and the need for immunosuppression limit the impact of transplantation. The …

Induced pluripotent stem cells—opportunities for disease modelling and drug discovery

M Grskovic, A Javaherian, B Strulovici… - Nature reviews Drug …, 2011 - nature.com
The ability to generate induced pluripotent stem cells (iPSCs) from patients, and an
increasingly refined capacity to differentiate these iPSCs into disease-relevant cell types …

[HTML][HTML] Activation of innate immunity is required for efficient nuclear reprogramming

J Lee, N Sayed, A Hunter, KF Au, WH Wong… - Cell, 2012 - cell.com
Retroviral overexpression of reprogramming factors (Oct4, Sox2, Klf4, c-Myc) generates
induced pluripotent stem cells (iPSCs). However, the integration of foreign DNA could …

[PDF][PDF] O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network

H Jang, TW Kim, S Yoon, SY Choi, TW Kang, SY Kim… - Cell stem cell, 2012 - cell.com
Summary O-linked-N-acetylglucosamine (O-GlcNAc) has emerged as a critical regulator of
diverse cellular processes, but its role in embryonic stem cells (ESCs) and pluripotency has …

Stem cell technology for neurodegenerative diseases

JS Lunn, SA Sakowski, J Hur… - Annals of neurology, 2011 - Wiley Online Library
Over the past 20 years, stem cell technologies have become an increasingly attractive
option to investigate and treat neurodegenerative diseases. In the current review, we …

C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells

B Di Stefano, JL Sardina, C van Oevelen, S Collombet… - Nature, 2014 - nature.com
CCAAT/enhancer binding protein-α (C/EBPα) induces transdifferentiation of B cells into
macrophages at high efficiencies and enhances reprogramming into induced pluripotent …

Induced pluripotent stem cells: Reprogramming platforms and applications in cell replacement therapy

A Al Abbar, SC Ngai, N Nograles, SY Alhaji… - BioResearch open …, 2020 - liebertpub.com
The generation of induced pluripotent stem cells (iPSCs) from differentiated mature cells is
one of the most promising technologies in the field of regenerative medicine. The ability to …

Decellularization and recellularization technologies in tissue engineering

RH Fu, YC Wang, SP Liu, TR Shih, HL Lin… - Cell …, 2014 - journals.sagepub.com
Decellularization is the process by which cells are discharged from tissues/organs, but all of
the essential cues for cell preservation and homeostasis are retained in a three-dimensional …